Expression and activity of taxane-metabolizing enzymes in ovarian tumors (Q46863452)

25 December 2017

title

Expression and activity of taxane-metabolizing enzymes in ovarian tumors (English)

1 reference

25 December 2017

author name string

Julie A DeLoia

1

1 reference

25 December 2017

William C Zamboni

2

1 reference

25 December 2017

Jacqueline M Jones

3

1 reference

25 December 2017

Sandra Strychor

4

1 reference

25 December 2017

Joseph L Kelley

5

1 reference

25 December 2017

Holly H Gallion

6

1 reference

25 December 2017

language of work or name

English

0 references

publication date

11 December 2007

1 reference

25 December 2017

published in

Gynecologic Oncology

1 reference

25 December 2017

volume

108

1 reference

25 December 2017

issue

2

1 reference

25 December 2017

page(s)

355-360

1 reference

25 December 2017

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.029

Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.029

Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.029

Disposition of docetaxel in the presence of P-glycoprotein inhibition by intravenous administration of R101933.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.029

P-Glycoprotein Expression as a Predictor of the Outcome of Therapy for Neuroblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.029

P-glycoprotein expression: critical determinant in the response to osteosarcoma chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.029

Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.029

Cytochrome P-450 3A4: regulation and role in drug metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.029

Explaining interindividual variability of docetaxel pharmacokinetics and pharmacodynamics in Asians through phenotyping and genotyping strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.029

Gene structure of CYP2C8 and extrahepatic distribution of the human CYP2Cs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.029

Expression of paclitaxel-inactivating CYP3A activity in human colorectal cancer: implications for drug therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.029

Prediction of response to docetaxel by CYP3A4 mRNA expression in breast cancer tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.029

Induction of cytochrome P450 3A4 by docetaxel in peripheral mononuclear cells and its expression in lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.029

CYP2C and IL-6 expression in breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.029

Interindividual variability and tissue-specificity in the expression of cytochrome P450 3A mRNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.029

Comparative analysis of CYP3A expression in human liver suggests only a minor role for CYP3A5 in drug metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.029

Positional cloning of ZNF217 and NABC1: genes amplified at 20q13.2 and overexpressed in breast carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.029

Sensitive liquid chromatography-mass spectrometry assay for quantitation of docetaxel and paclitaxel in human plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.029

A potential role for the estrogen-metabolizing cytochrome P450 enzymes in human breast carcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.029

Transcriptional regulation and expression of CYP3A4 in hepatocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.029

Multivariate analysis for prognostic significance of histologic subtype, GST-pi, MDR-1, and p53 in stages II-IV ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.029

Multidrug resistance gene-1 is a useful predictor of Paclitaxel-based chemotherapy for patients with ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.029

The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.029

The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.10.029

10.1016/J.YGYNO.2007.10.029

7 January 2021

Identifiers

DOI

1 reference

25 December 2017

1 reference

25 December 2017